Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents

References

• Megraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin. Microbiol. Rev.20(2), 280–322 (2007).
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, Megraud F, O’Morain C et al.; The European Helicobacter Study Group (EHSG). Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut56(6), 772–781 (2007).
   PubMed Web of Science ®Google Scholar
• Megraud F. H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut53(9), 1374–1384 (2004).
   PubMed Web of Science ®Google Scholar
• Jafri NS, Hornung CA, Howden CW. Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment. Ann. Intern. Med.148(12), 923–931 (2008).
   PubMed Web of Science ®Google Scholar
• Graham DY, Shiotani A. New concepts of resistance in the treatment of Helicobacter pylori infections. Nat. Clin. Pract. Gastroenterol. Hepatol.5(6), 321–331 (2008).
   PubMedGoogle Scholar
• Lesbros-Pantoflickova D, Corthésy-Theulaz I, Blum AL. Helicobacter pylori and probiotics. J. Nutr.137(Suppl. 2), 812S–818S (2007).
   PubMed Web of Science ®Google Scholar
• Graham DY, Lu H, Yamaoka Y. Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond. Drugs68(6), 725–736 (2008).
   PubMed Web of Science ®Google Scholar
• Boyanova L. Prevalence of multidrug-resistant Helicobacter pylori in Bulgaria. J. Med. Microbiol.58(Pt 7), 930–935 (2009).
   PubMedGoogle Scholar
• Ghose C, Perez-Perez GI, van Doorn LJ, Domínguez-Bello MG, Blaser MJ. High frequency of gastric colonization with multiple Helicobacter pylori strains in Venezuelan subjects. J. Clin. Microbiol.43(6), 2635–2641 (2005).
   PubMed Web of Science ®Google Scholar
• Bogaerts P, Berhin C, Nizet H, Glupczynski Y. Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium. Helicobacter11(5), 441–445 (2006).
   PubMed Web of Science ®Google Scholar
• Matteo MJ, Granados G, Olmos M, Wonaga A, Catalano M. Helicobacter pylori amoxicillin heteroresistance due to point mutations in PBP-1A in isogenic isolates. J. Antimicrob. Chemother.61(3), 474–477 (2008).
   PubMed Web of Science ®Google Scholar
• Boyanova L, Gergova G, Nikolov R et al. Prevalence and evolution of Helicobacter pylori resistance to 6 antibacterial agents over 12 years and correlation between susceptibility testing methods. Diagn. Microbiol. Infect. Dis.60(4), 409–415 (2008).
   PubMed Web of Science ®Google Scholar
• Kawai T, Yamagishi T, Yagi K et al. Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivities. J. Gastroenterol. Hepatol.23(Suppl. 2), S171–S174 (2008).
   PubMedGoogle Scholar
• Burucoa C, Garnier M, Silvain C, Fauchère JL. Quadruplex real-time PCR assay using allele-specific scorpion primers for detection of mutations conferring clarithromycin resistance to Helicobacter pylori. J. Clin. Microbiol.46(7), 2320–2326 (2008).
   PubMed Web of Science ®Google Scholar
• Raymond J, Burucoa C, Pietrini O et al. Clarithromycin resistance in Helicobacter pylori strains isolated from French children: prevalence of the different mutations and coexistence of clones harboring two different mutations in the same biopsy. Helicobacter12(2), 157–163 (2007).
   PubMedGoogle Scholar
• Rimbara E, Noguchi N, Kijima H, Yamaguchi T, Kawai T, Sasatsu M. Mutations in the 23S rRNA gene of clarithromycin-resistant Helicobacter pylori from Japan. Int. J. Antimicrob. Agents.30(3), 250–254 (2007).
   PubMedGoogle Scholar
• Garrido L, Toledo H. Novel genotypes in Helicobacter pylori involving domain V of the 23S rRNA gene. Helicobacter12(5), 505–509 (2007).
   PubMedGoogle Scholar
• Kaakoush NO, Asencio C, Mégraud F, Mendz GL. A redox basis for metronidazole resistance in Helicobacter pylori. Antimicrob. Agents Chemother.53(5), 1884–1891 (2009).
   PubMedGoogle Scholar
• Rimbara E, Noguchi N, Kawai T, Sasatsu M. Mutations in penicillin-binding proteins 1, 2 and 3 are responsible for amoxicillin resistance in Helicobacter pylori. J. Antimicrob. Chemother.61(5), 995–998 (2008).
   PubMed Web of Science ®Google Scholar
• Co EM, Schiller NL. Resistance mechanisms in an in vitro-selected amoxicillin-resistant strain of Helicobacter pylori. Antimicrob. Agents Chemother.50(12), 4174–4176 (2006).
   PubMed Web of Science ®Google Scholar
• Tseng YS, Wu DC, Chang CY et al. Amoxicillin resistance with β-lactamase production in Helicobacter pylori. Eur. J. Clin. Invest.39(9), 807–812 (2009).
   PubMed Web of Science ®Google Scholar
• Nonaka L, Connell SR, Taylor DE. 16S rRNA mutations that confer tetracycline resistance in Helicobacter pylori decrease drug binding in Escherichia coli ribosomes. J. Bacteriol.187(11), 3708–3712 (2005).
   PubMedGoogle Scholar
• Anoushiravani M, Falsafi T, Niknam V. Proton motive force-dependent efflux of tetracycline in clinical isolates of Helicobacter pylori. J. Med. Microbiol.58(Pt 10), 1309–1313 (2009).
   PubMed Web of Science ®Google Scholar
• Hung K-H, Sheu B-S, Chang W-L, Wu H-M, Liu C-C, Wu J-J. Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan. Helicobacter14(1), 61–65 (2009).
   PubMedGoogle Scholar
• Nishizawa T, Suzuki H, Hibi T. Quinolone-based third-line therapy for Helicobacter pylori eradication. J. Clin. Biochem. Nutr.44(2), 119–124 (2009).
   PubMedGoogle Scholar
• Glocker E, Bogdan C, Kist M. Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from Germany. J. Antimicrob. Chemother.59(5), 874–879 (2007).
   PubMed Web of Science ®Google Scholar
• Su Z, Xu H, Zhang C et al. Mutations in Helicobacter pylori porD and oorD genes may contribute to furazolidone resistance. Croat. Med. J.47(3), 410–415 (2006).
   PubMedGoogle Scholar
• Vakil N. Helicobacter pylori treatment: is sequential or quadruple therapy the answer? Rev. Gastroenterol. Disord.8(2), 77–82 (2008).
   PubMedGoogle Scholar
• Toracchio S, Marzio L. Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998–2002. Dig. Liver Dis.35(8), 541–545 (2003).
   PubMedGoogle Scholar
• Chisholm SA, Teare EL, Davies K, Owen RJ. Surveillance of primary antibiotic resistance of Helicobacter pylori at centres in England and Wales over a six-year period (2000–2005). Euro Surveill.12(7), E3–E4 (2007).
   PubMedGoogle Scholar
• Kobayashi I, Murakami K, Kato M et al. Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005. J. Clin. Microbiol.45(12), 4006–4010 (2007).
   PubMed Web of Science ®Google Scholar
• Buzás GM, Lotz G, Kiss A. The epidemiology of clarithromycin resistance of Helicobacter pylori infection in Hungary. Orv. Hetil.148(31), 1461–1467 (2007).
   PubMedGoogle Scholar
• Koletzko S, Richy F, Bontems P et al. Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe. Gut55(12), 1711–1716 (2006).
   PubMed Web of Science ®Google Scholar
• Dzierzanowska-Fangrat K, Rozynek E, Celińska-Cedro D et al. Antimicrobial resistance of Helicobacter pylori in Poland: a multicentre study. Int. J. Antimicrob. Agents.26(3), 230–234 (2005).
   PubMed Web of Science ®Google Scholar
• Boyanova L, Ilieva J, Gergova G et al. Evaluation of clinical and socio–demographic risk factors for antibacterial resistance of Helicobacter pylori in Bulgaria. J. Med. Microbiol.58(Pt 1), 94–100 (2009).
   PubMedGoogle Scholar
• Fujimura S, Kato S, Iinuma K, Watanabe A. in vitro activity of fluoroquinolone and the gyrA gene mutation in Helicobacter pylori strains isolated from children. J. Med. Microbiol.53(10), 1019–1022 (2004).
   PubMedGoogle Scholar
• Kato S, Fujimura S. Primary antimicrobial resistance of Helicobacter pylori in children during the past 9 years. Pediatr. Int. (2009) (Epub ahead of print).
   Google Scholar
• Sherif M, Mohran Z, Fathy H, Rockabrand DM, Rozmajzl PJ, Frenck RW. Universal high-level primary metronidazole resistance in Helicobacter pylori isolated from children in Egypt. J. Clin. Microbiol.42(10), 4832–4834 (2004).
   PubMed Web of Science ®Google Scholar
• De Francesco V, Margiotta M, Zullo A et al. Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in Italy. J. Antimicrob. Chemother.59(4), 783–785 (2007).
   PubMed Web of Science ®Google Scholar
• Zullo A, Perna F, Hassan C et al. Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy. Aliment. Pharmacol. Ther.25(12), 1429–1434 (2007).
   PubMed Web of Science ®Google Scholar
• Lee JH, Shin JH, Roe IH et al. Impact of clarithromycin resistance on eradication of Helicobacter pylori in infected adults. Antimicrob. Agents Chemother.49(4), 1600–1603 (2005).
   PubMed Web of Science ®Google Scholar
• Campos J, Ferech M, Lázaro E et al. Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data. J. Antimicrob. Chemother.60(3), 698–701 (2007).
   PubMed Web of Science ®Google Scholar
• Agudo S, Alarcón T, Cibrelus L, Urruzuno P, Martínez M, López-Brea M. High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children. Rev. Esp. Quimioter.22(2), 88–92 (2009).
   PubMed Web of Science ®Google Scholar
• Lopes AI, Oleastro M, Palha A, Fernandes A, Monteiro L. Antibiotic-resistant Helicobacter pylori strains in Portuguese children. Pediatr. Infect. Dis. J.24(5), 404–409 (2005).
   PubMedGoogle Scholar
• Kalach N, Serhal L, Asmar E et al.Helicobacter pylori primary resistant strains over 11 years in French children. Diagn. Microbiol. Infect. Dis.59(2), 217–222 (2007).
   PubMedGoogle Scholar
• Storskrubb T, Aro P, Ronkainen J et al. Antimicrobial susceptibility of Helicobacter pylori strains in a random adult Swedish population. Helicobacter11(4), 224–230 (2006).
   PubMed Web of Science ®Google Scholar
• Yuen B, Zbinden R, Fried M, Bauerfeind P, Bernardi M. Cultural recovery and determination of antimicrobial susceptibility in Helicobacter pylori by using commercial transport and isolation media. Infection33(2), 77–81 (2005).
   PubMed Web of Science ®Google Scholar
• Onder G, Aydin A, Akarca U, Tekin F, Ozutemiz O, Ilter T. High Helicobacter pylori resistance rate to clarithromycin in Turkey. J. Clin. Gastroenterol.41(8), 747–750 (2007).
   PubMedGoogle Scholar
• Thyagarajan SP, Ray P, Das BK et al. Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: multicentric study. J. Gastroenterol. Hepatol.2003 18(12), 1373–1378 (2003).
   PubMedGoogle Scholar
• Datta S, Chattopadhyay S, Patra R et al. Most Helicobacter pylori strains of Kolkata in India are resistant to metronidazole but susceptible to other drugs commonly used for eradication and ulcer therapy. Aliment. Pharmacol. Ther.22(1), 51–57 (2005).
   PubMed Web of Science ®Google Scholar
• Rafeey M, Ghotaslou R, Nikvash S, Hafez AA. Primary resistance in Helicobacter pylori isolated in children from Iran. J. Infect. Chemother.13(5), 291–295 (2007).
   PubMedGoogle Scholar
• Kim N, Kim JM, Kim CH et al. Institutional difference of antibiotic resistance of Helicobacter pylori strains in Korea. J. Clin. Gastroenterol.40(8), 683–687 (2006).
   PubMed Web of Science ®Google Scholar
• Domingo D, Alarcón T, Vega AE, García JA, Martínez MJ, López-Brea M. Microbiological factors that influence the eradication of Helicobacter pylori in adults and children. Enferm. Infecc. Microbiol. Clin.20(9), 431–434 (2002).
   PubMedGoogle Scholar
• Nahar S, Mukhopadhyay AK, Khan R et al. Antimicrobial susceptibility of Helicobacter pylori strains isolated in Bangladesh. J. Clin. Microbiol.42(10), 4856–4858 (2004).
   PubMed Web of Science ®Google Scholar
• Asrat D, Kassa E, Mengistu Y, Nilsson I, Wadström T. Antimicrobial susceptibility pattern of Helicobacter pylori strains isolated from adult dyspeptic patients in Tikur Anbassa University Hospital, Addis Ababa, Ethiopia. Ethiop. Med. J.42(2), 79–85 (2004).
   PubMedGoogle Scholar
• Kim JM, Kim JS, Kim N, Kim SG, Jung HC, Song IS. Comparison of primary and secondary antimicrobial minimum inhibitory concentrations for Helicobacter pylori isolated from Korean patients. Int. J. Antimicrob. Agents.28(1), 6–13 (2006).
   PubMedGoogle Scholar
• Godoy AP, Ribeiro ML, Benvengo YH et al. Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates. BMC Gastroenterol.3, 20 (2003).
   PubMedGoogle Scholar
• Elviss NC, Owen RJ, Xerry J, Walker AM, Davies K. Helicobacter pylori antibiotic resistance patterns and genotypes in adult dyspeptic patients from a regional population in North Wales. J. Antimicrob. Chemother.54(2), 435–440 (2004).
   PubMedGoogle Scholar
• Vallejos C, Garrido L, Cáceres D et al. Prevalence of metronidazole, clarithromycin and tetracycline resistance in Helicobacter pylori isolated from Chilean patients. Rev. Med. Chil.135(3), 287–293 (2007).
   PubMed Web of Science ®Google Scholar
• Romano M, Iovene MR, Russo MI et al. Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates. J. Clin. Pathol.61(10), 1112–1115 (2008).
   PubMed Web of Science ®Google Scholar
• van de Sande-Bruinsma N, Grundmann H, Verloo D et al.; European Antimicrobial Resistance Surveillance System Group; European Surveillance of Antimicrobial Consumption Project Group. Antimicrobial drug use and resistance in Europe. Emerg. Infect. Dis.14(11), 1722–1730 (2008).
   PubMed Web of Science ®Google Scholar
• Miyachi H, Miki I, Aoyama N et al. Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan. Helicobacter11(4), 243–249 (2006).
   PubMed Web of Science ®Google Scholar
• Mégraud F. Helicobacter pylori: bacteriological aspects, diagnostic methods, and susceptibility to antibiotics. Presse Medicale.37(3 Part 2), 507–512 (2008).
   PubMedGoogle Scholar
• Alarcón T, de la Obra P, Domingo D, García-Campos JA, Díaz-Regañón J, López-Brea M. in vitro activity of furazolidone and nitrofurantoin in Helicobacter pylori clinical isolates and study of mutation rate. Rev. Esp. Quimioter.18(4), 313–318 (2005).
   PubMedGoogle Scholar
• De Francesco V, Ierardi E, Hassan C, Zullo A. Furazolidone therapy for Helicobacter pylori: is it effective and safe? World J. Gastroenterol.15(15), 1914–1915 (2009).
   PubMedGoogle Scholar
• Glocker E, Stueger HP, Kist M. Quinolone resistance in Helicobacter pylori isolates in Germany. Antimicrob. Agents Chemother.51(1), 346–349 (2007).
   PubMed Web of Science ®Google Scholar
• Wueppenhorst N, Stueger HP, Kist M, Glocker E. Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany. J. Antimicrob. Chemother.63(4), 648–653 (2009).
   PubMed Web of Science ®Google Scholar
• Kim JM, Kim JS, Jung HC, Kim N, Kim YJ, Song IS. Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea. Antimicrob. Agents Chemother.48(12), 4843–4847 (2004).
   PubMed Web of Science ®Google Scholar
• Janssen MJ, Hendrikse L, de Boer SY et al.Helicobacter pylori antibiotic resistance in a Dutch region: trends over time. Neth. J. Med.64(6), 191–195 (2006).
   PubMedGoogle Scholar
• Chang WL, Sheu BS, Cheng HC, Yang YJ, Yang HB, Wu JJ. Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan. J. Gastroenterol. Hepatol.24(7), 1230–1235 (2009).
   PubMed Web of Science ®Google Scholar
• Feydt-Schmidt A, Rüssmann H, Lehn N et al. Fluorescence in situ hybridization vs. epsilometer test for detection of clarithromycin-susceptible and clarithromycin-resistant Helicobacter pylori strains in gastric biopsies from children. Aliment. Pharmacol. Ther.16(12), 2073–2079 (2002).
   PubMed Web of Science ®Google Scholar
• Samra Z, Shmuely H, Niv Y et al. Resistance of Helicobacter pylori isolated in Israel to metronidazole, clarithromycin, tetracycline, amoxicillin and cefixime. J. Antimicrob, Chemother.49(6), 1023–1026 (2002).
   PubMedGoogle Scholar
• Lui SY, Yeoh KG, Ho B. Metronidazole-resistant Helicobacter pylori is more prevalent in patients with nonulcer dyspepsia than in peptic ulcer patients in a multiethnic Asian population. J. Clin. Microbiol.41(11), 5011–5014 (2003).
   PubMed Web of Science ®Google Scholar
• Koivisto TT, Rautelin HI, Voutilainen ME et al. Primary Helicobacter pylori resistance to metronidazole and clarithromycin in the Finnish population. Aliment. Pharmacol. Ther.19(9), 1009–1017 (2004).
   PubMed Web of Science ®Google Scholar
• Aguemon B, Struelens M, Devière J et al. Primary antibiotic resistance and effectiveness of Helicobacter pylori triple therapy in ulcero-inflammatory pathologies of the upper digestive tract. Acta Gastroenterol. Belg.68(3), 287–293 (2005).
   PubMed Web of Science ®Google Scholar
• John Albert M, Al-Mekhaizeem K, Neil L et al. High prevalence and level of resistance to metronidazole, but lack of resistance to other antimicrobials in Helicobacter pylori, isolated from a multiracial population in Kuwait. Aliment. Pharmacol. Ther.24(9), 1359–1366 (2006).
   PubMedGoogle Scholar
• Carothers JJ, Bruce MG, Hennessy TW et al. The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection. Clin. Infect. Dis.44(2), e5–e8 (2007).
   Google Scholar
• Tüzün Y, Bayan K, Yilmaz S, Dursun M, Ozekinci T. The prevalence of primary and secondary Helicobacter pylori resistance to clarithromycin and probable contributing cofactors: data from southeastern Anatolia. Hepatogastroenterology55(81), 289–293 (2008).
   PubMedGoogle Scholar
• Ahmad N, Zakaria WR, Abdullah SA, Mohamed R. Characterization of clarithromycin resistance in Malaysian isolates of Helicobacter pylori.World J. Gastroenterol.15(25), 3161–3165 (2009).
   PubMed Web of Science ®Google Scholar
• Filipec Kanizaj T, Katicic M, Skurla B, Ticak M, Plecko V, Kalenic S. Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens. Helicobacter14(1), 29–35 (2009).
   PubMed Web of Science ®Google Scholar
• Henao SC, Otero W, Ángel LA, Martínez JD. Primary resistance to metronidazole in Helicobacter pylori isolates in adult patients in Bogotá, Colombia. Rev. Col. Gastroenterol.24(1), 10–15 (2009).
   Google Scholar
• Laine L, Hunt R, El-Zimaity H, Nguyen B, Osato M, Spénard J. Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial. Am. J. Gastroenterol.98(3), 562–567 (2003).
   PubMed Web of Science ®Google Scholar
• Cheng H, Hu FL, Li J. Influence of resistance of Helicobacter pylori to antibiotics on the Helicobacter pylori eradication regimens. Zhonghua Yi Xue Za Zhi86(38), 2679–2682 (2006).
   PubMedGoogle Scholar